ARCUTIS BIOTHERAPEUTICS Receives Buy Recommendation and Projected 82.88% Upside from Jefferies Analysts
🌥️Trending News Arcutis Biotherapeutics ($NASDAQ:ARQT) is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for various skin [...]
ARCUTIS BIOTHERAPEUTICS Gains Major Investor Support With 30.7% Increase From Rubric Capital Management Lp
☀️Trending News ARCUTIS BIOTHERAPEUTICS ($NASDAQ:ARQT) is a biopharmaceutical company that focuses on developing treatments for skin diseases. The company's mission [...]
Mizuho Upgrades Arcutis Biotherapeutics to ‘Buy’ on Zoryve Sales
🌥️Trending News Arcutis Biotherapeutics ($NASDAQ:ARQT) is a biotechnology company that has developed innovative therapies for skin conditions. Recently, the firm [...]
Is Selling Arcutis Biotherapeutics Inc Stock the Right Move Friday Morning?
🌥️Trending News Is Selling Arcutis Biotherapeutics ($NASDAQ:ARQT) Inc. Stock the Right Move Friday Morning? To answer this question, one must [...]
Arcutis Biotherapeutics Soars 28% After FDA Approval for Dermatology Drug
☀️Trending News Arcutis Biotherapeutics ($NASDAQ:ARQT), a biopharmaceutical company focused on developing and commercializing treatments for immune-mediated dermatologic diseases, saw its [...]
Arcutis Biotherapeutics Receives Average Recommendation of ‘Moderate Buy’ from Brokerages
🌥️Trending News Arcutis Biotherapeutics ($NASDAQ:ARQT), Inc. is a biotechnology company focused on developing treatments for immune-mediated dermatological diseases and conditions. [...]
FDA Reviewing Arcutis Biotherapeutics’ Lead Product for Label Expansion
🌥️Trending News Arcutis Biotherapeutics ($NASDAQ:ARQT), a specialty biopharmaceutical company focused on developing, manufacturing, and commercializing treatments for rare and underserved [...]
Jonestrading Gives Arcutis Biotherapeutics a Hold Rating
🌥️Trending News Arcutis Biotherapeutics ($NASDAQ:ARQT) is a biopharmaceutical company focused on developing and commercializing treatments for skin diseases. The company’s [...]
ARCUTIS BIOTHERAPEUTICS Reports Second Quarter FY2023 Earnings Results on August 8th
🌥️Earnings Overview On August 8, 2023, ARCUTIS BIOTHERAPEUTICS ($NASDAQ:ARQT) reported their earnings for the second quarter of FY 2023 (ending [...]
Arcutis Biotherapeutics: Potential FDA Approval Before 2023 Makes Investment Worthwhile
Trending News ☀️ Arcutis Biotherapeutics ($NASDAQ:ARQT) is an emerging biopharmaceutical company that is focused on developing treatments for skin diseases. [...]
